JIANDE INT'L (00865) Income Statement & Earnings

0.040
0.0000.00%

Not Open Apr 24 09:00 CST

233.52MMarket Cap-40.00P/E (TTM)

JIANDE INT'L (00865) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

Turnover

18.95%91.28M

0.00%63.94M

-72.43%76.74M

241.97%63.93M

6.15%278.29M

-91.05%18.7M

148.23%262.15M

799.48%208.89M

-78.00%105.61M

-94.46%23.22M

Operating income

18.95%91.28M

0.00%63.94M

-72.43%76.74M

241.97%63.93M

6.15%278.29M

-91.05%18.7M

148.23%262.15M

799.48%208.89M

-78.00%105.61M

-94.46%23.22M

Cost of sales

-20.74%-84.28M

-6.93%-59.62M

71.07%-69.8M

-346.64%-55.76M

-35.13%-241.28M

91.67%-12.48M

-174.85%-178.56M

-863.90%-149.8M

79.80%-64.97M

94.43%-15.54M

Operating expenses

-20.74%-84.28M

-6.93%-59.62M

71.07%-69.8M

-346.64%-55.76M

-35.13%-241.28M

91.67%-12.48M

-174.85%-178.56M

-863.90%-149.8M

79.80%-64.97M

94.43%-15.54M

Gross profit

0.98%7M

-47.25%4.31M

-81.26%6.94M

31.62%8.18M

-55.73%37.01M

-89.49%6.21M

105.68%83.59M

669.16%59.09M

-74.34%40.64M

-94.50%7.68M

Selling expenses

11.73%-3.1M

22.91%-1.81M

57.80%-3.51M

5.97%-2.35M

-13.27%-8.32M

40.52%-2.5M

-39.77%-7.35M

-28.93%-4.2M

36.05%-5.26M

-5.17%-3.26M

Administrative expenses

10.32%-11.97M

13.56%-5.69M

12.07%-13.35M

15.99%-6.58M

27.41%-15.18M

27.58%-7.84M

3.35%-20.91M

-6.11%-10.82M

-15.01%-21.64M

-32.37%-10.2M

Revaluation surplus

85.36%-1.64M

88.96%-203K

-10,458.33%-11.19M

-29.44%-1.84M

103.72%108K

1.93%-1.42M

-129.04%-2.9M

-161.84%-1.45M

25.82%-1.27M

-131.51%-553K

-Changes in the fair value of investment property

85.36%-1.64M

88.96%-203K

-10,458.33%-11.19M

-29.44%-1.84M

103.72%108K

1.93%-1.42M

-129.04%-2.9M

-161.84%-1.45M

25.82%-1.27M

-131.51%-553K

Impairment and provision

-128.57%-136K

----

164.44%476K

220.62%622K

103.30%180K

--194K

---5.46M

----

-Impairment of property, machinery and equipment

----

---5.04M

----

-Other impairment is provision

-128.57%-136K

----

164.44%476K

220.62%622K

142.15%180K

--194K

---427K

----

Special items of operating profit

-15.71%2.89M

-18.39%1.47M

53.69%3.43M

25.00%1.8M

298.14%2.23M

179.03%1.44M

79.71%-1.13M

-190.74%-1.82M

-174.17%-5.55M

-47.43%2.01M

Operating profit

59.60%-6.95M

-1,017.44%-1.92M

-207.39%-17.21M

95.60%-172K

-65.05%16.02M

-109.58%-3.91M

562.03%45.84M

1,044.81%40.8M

-94.95%6.92M

-103.21%-4.32M

Financing cost

-100.00%-14K

-250.00%-7K

12.50%-7K

66.67%-2K

20.00%-8K

25.00%-6K

64.29%-10K

57.89%-8K

22.22%-28K

44.12%-19K

Earning before tax

59.54%-6.96M

-1,008.62%-1.93M

-207.49%-17.21M

95.55%-174K

-65.06%16.01M

-109.60%-3.91M

564.57%45.83M

1,040.49%40.79M

-94.97%6.9M

-103.23%-4.34M

Tax

100.00%-1K

78.68%-776K

-186.10%-24.1M

-802.70%-3.64M

38.08%-8.42M

103.78%518K

-85.15%-13.6M

-1,018.94%-13.71M

80.75%-7.35M

96.40%-1.23M

After-tax profit from continuing operations

83.14%-6.97M

29.08%-2.71M

-644.27%-41.31M

-12.31%-3.81M

-76.45%7.59M

-112.54%-3.4M

7,245.45%32.23M

586.91%27.08M

-100.46%-451K

-105.55%-5.56M

Earning after tax

83.14%-6.97M

29.08%-2.71M

-644.27%-41.31M

-12.31%-3.81M

-76.45%7.59M

-112.54%-3.4M

7,245.45%32.23M

586.91%27.08M

-100.46%-451K

-105.55%-5.56M

Minority profit

111.81%85K

-1,675.00%-252K

-123.35%-720K

133.33%16K

240.66%3.08M

90.84%-48K

151.60%905K

60.87%-524K

-2,884.13%-1.75M

-200.53%-1.34M

Profit attributable to shareholders

82.63%-7.05M

35.95%-2.45M

-1,000.60%-40.59M

-14.40%-3.83M

-85.61%4.51M

-112.13%-3.35M

2,303.76%31.32M

753.71%27.61M

-98.68%1.3M

-104.27%-4.22M

Basic earnings per share

82.86%-0.0012

42.86%-0.0004

-975.00%-0.007

-16.67%-0.0007

-85.19%0.0008

-112.77%-0.0006

2,600.00%0.0054

771.43%0.0047

-98.82%0.0002

-104.12%-0.0007

Diluted earnings per share

82.86%-0.0012

42.86%-0.0004

-975.00%-0.007

-16.67%-0.0007

-85.19%0.0008

-112.77%-0.0006

2,600.00%0.0054

0.0047

0.0002

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

National Health Accounting Firm Co., Ltd.

Deloitte Touche Tohmatsu会计师事务所

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021
Turnover	18.95%91.28M	0.00%63.94M	-72.43%76.74M	241.97%63.93M	6.15%278.29M	-91.05%18.7M	148.23%262.15M	799.48%208.89M	-78.00%105.61M	-94.46%23.22M
Operating income	18.95%91.28M	0.00%63.94M	-72.43%76.74M	241.97%63.93M	6.15%278.29M	-91.05%18.7M	148.23%262.15M	799.48%208.89M	-78.00%105.61M	-94.46%23.22M
Cost of sales	-20.74%-84.28M	-6.93%-59.62M	71.07%-69.8M	-346.64%-55.76M	-35.13%-241.28M	91.67%-12.48M	-174.85%-178.56M	-863.90%-149.8M	79.80%-64.97M	94.43%-15.54M
Operating expenses	-20.74%-84.28M	-6.93%-59.62M	71.07%-69.8M	-346.64%-55.76M	-35.13%-241.28M	91.67%-12.48M	-174.85%-178.56M	-863.90%-149.8M	79.80%-64.97M	94.43%-15.54M
Gross profit	0.98%7M	-47.25%4.31M	-81.26%6.94M	31.62%8.18M	-55.73%37.01M	-89.49%6.21M	105.68%83.59M	669.16%59.09M	-74.34%40.64M	-94.50%7.68M
Selling expenses	11.73%-3.1M	22.91%-1.81M	57.80%-3.51M	5.97%-2.35M	-13.27%-8.32M	40.52%-2.5M	-39.77%-7.35M	-28.93%-4.2M	36.05%-5.26M	-5.17%-3.26M
Administrative expenses	10.32%-11.97M	13.56%-5.69M	12.07%-13.35M	15.99%-6.58M	27.41%-15.18M	27.58%-7.84M	3.35%-20.91M	-6.11%-10.82M	-15.01%-21.64M	-32.37%-10.2M
Revaluation surplus	85.36%-1.64M	88.96%-203K	-10,458.33%-11.19M	-29.44%-1.84M	103.72%108K	1.93%-1.42M	-129.04%-2.9M	-161.84%-1.45M	25.82%-1.27M	-131.51%-553K
-Changes in the fair value of investment property	85.36%-1.64M	88.96%-203K	-10,458.33%-11.19M	-29.44%-1.84M	103.72%108K	1.93%-1.42M	-129.04%-2.9M	-161.84%-1.45M	25.82%-1.27M	-131.51%-553K
Impairment and provision	-128.57%-136K	----	164.44%476K	220.62%622K	103.30%180K	--194K	---5.46M	----	----	----
-Impairment of property, machinery and equipment	----	----	----	----	----	----	---5.04M	----	----	----
-Other impairment is provision	-128.57%-136K	----	164.44%476K	220.62%622K	142.15%180K	--194K	---427K	----	----	----
Special items of operating profit	-15.71%2.89M	-18.39%1.47M	53.69%3.43M	25.00%1.8M	298.14%2.23M	179.03%1.44M	79.71%-1.13M	-190.74%-1.82M	-174.17%-5.55M	-47.43%2.01M
Operating profit	59.60%-6.95M	-1,017.44%-1.92M	-207.39%-17.21M	95.60%-172K	-65.05%16.02M	-109.58%-3.91M	562.03%45.84M	1,044.81%40.8M	-94.95%6.92M	-103.21%-4.32M
Financing cost	-100.00%-14K	-250.00%-7K	12.50%-7K	66.67%-2K	20.00%-8K	25.00%-6K	64.29%-10K	57.89%-8K	22.22%-28K	44.12%-19K
Earning before tax	59.54%-6.96M	-1,008.62%-1.93M	-207.49%-17.21M	95.55%-174K	-65.06%16.01M	-109.60%-3.91M	564.57%45.83M	1,040.49%40.79M	-94.97%6.9M	-103.23%-4.34M
Tax	100.00%-1K	78.68%-776K	-186.10%-24.1M	-802.70%-3.64M	38.08%-8.42M	103.78%518K	-85.15%-13.6M	-1,018.94%-13.71M	80.75%-7.35M	96.40%-1.23M
After-tax profit from continuing operations	83.14%-6.97M	29.08%-2.71M	-644.27%-41.31M	-12.31%-3.81M	-76.45%7.59M	-112.54%-3.4M	7,245.45%32.23M	586.91%27.08M	-100.46%-451K	-105.55%-5.56M
Earning after tax	83.14%-6.97M	29.08%-2.71M	-644.27%-41.31M	-12.31%-3.81M	-76.45%7.59M	-112.54%-3.4M	7,245.45%32.23M	586.91%27.08M	-100.46%-451K	-105.55%-5.56M
Minority profit	111.81%85K	-1,675.00%-252K	-123.35%-720K	133.33%16K	240.66%3.08M	90.84%-48K	151.60%905K	60.87%-524K	-2,884.13%-1.75M	-200.53%-1.34M
Profit attributable to shareholders	82.63%-7.05M	35.95%-2.45M	-1,000.60%-40.59M	-14.40%-3.83M	-85.61%4.51M	-112.13%-3.35M	2,303.76%31.32M	753.71%27.61M	-98.68%1.3M	-104.27%-4.22M
Basic earnings per share	82.86%-0.0012	42.86%-0.0004	-975.00%-0.007	-16.67%-0.0007	-85.19%0.0008	-112.77%-0.0006	2,600.00%0.0054	771.43%0.0047	-98.82%0.0002	-104.12%-0.0007
Diluted earnings per share	82.86%-0.0012	42.86%-0.0004	-975.00%-0.007	-16.67%-0.0007	-85.19%0.0008	-112.77%-0.0006	2,600.00%0.0054	0.0047	0.0002
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--
Auditor	--	--	National Health Accounting Firm Co., Ltd.	--	National Health Accounting Firm Co., Ltd.	--	National Health Accounting Firm Co., Ltd.	--	Deloitte Touche Tohmatsu会计师事务所	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"